US2012202974A1PendingUtilityA1
Process for the purification of fc-containing proteins
Est. expiryJan 17, 2027(~0.5 yrs left)· nominal 20-yr term from priority
A61P 35/00A61P 37/02A61P 31/04C07K 1/18
34
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a process for the purification of an Fc-containing protein based on cation exchange chromatography.
Claims
exact text as granted — not AI-modified1 . A method for separating and purifying an Fc-containing protein from a fluid comprising at least a cation exchange chromatography purification step comprising:
(a) binding an Fc protein containing fluid comprising an Fc-containing protein to a cation exchange chromatography resing; (b) washing the cation chromatography resin with a buffer at a pH about 1 unit below the isoelectric point of the Fc-containing protein, the buffer having a conductivity of about 2 to 6 mS/cm; (c) eluting the Fc-containing protein with a buffer at a pH about 1 unit below the isoelectric point of the Fc-containing protein with an increasing salt gradient; and (d) applying the eluent of step (c) to an anionic exchange chromatography matrix or a hydrophobic interaction chromatography matrix.
2 . The method according to claim 1 , wherein the method comprises applying the eluted Fc-containing protein to an anion exchange chromatography matrix, eluting the Fc-containing protein from the anion exchange chromatography matrix, applying the eluted Fc containing protein to a hydrophobic interaction chromatography matrix and eluting the Fc-containing protein from the hydrophobic interaction chromatography matrix.
3 . The method according to claim 1 , wherein the method comprises applying the eluted Fc-containing protein to a hydrophobic interaction chromatography matrix, eluting the Fc-containing protein from the hydrophobic interaction chromatography matrix, applying the eluted Fc-containing protein to an anion exchange chromatography matrix and eluting the Fc-containing protein from the anion exchange chromatography resin.
4 . The method according to claim 1 , wherein the binding of the Fc-containing protein in step (a) is carried out at pH below 5.
5 . The method according to claim 1 , wherein the Fc-containing protein is diluted in water to a conductivity of less than 4 mS/cm at about pH 7.0 prior to its binding to the cation exchange resin in step (a).
6 . The method according to claim 1 , wherein the washing in step (b) is carried out at a pH from about 7 to about 8.5 at a conductivity of about 2 to 6 mS/cm.
7 . The method according to claim 1 , wherein the washing in step (b) is carried out with a phosphate buffer at about pH 8, having a conductivity of about 3.5 mS/cm.
8 . The method according to claim 1 , wherein the Fc-containing protein is eluted from the cation exchange resin with an increasing salt gradient at a conductivity ranging from about 2 to about 15 mS/cm at a pH of about 7 to about 8.5.
9 . The method according to claim 1 , wherein the Fc-containing protein is eluted from the cation exchange resin with an increasing NaCl gradient ranging from about 0 to about 150 mM at a pH ranging from about 7 to about pH 8.5.
10 . The method according to claim 1 , wherein cutting out the tail of the elution peak in step (c) is performed.
11 . The method according to claim 1 , wherein the cation exchange resin in step (a) is a strong cation exchange resin.
12 . The method according to claim 11 , wherein the strong cation exchange resin is Fractogel EMD SE Hicap (M) resin.
13 . The method according to claim 11 , wherein the resin is loaded at about pH 4, at a conductivity of about 15 mS/cm and at a dynamic capacity of about 40 to 47 g of Fc-containing protein per liter of packed cation exchange resin.
14 . The method according to claim 1 , wherein the eluate of the cation exchange resin resulting from step (c) has an HCP level of less than 10,000 ppm or of less than 5,000 ppm.
15 . The method according to claim 1 , wherein the eluate of the cation exchange resin resulting from step (c) has an aggregate level of less than 1%.
16 . The method according to claim 1 , wherein the eluate of the cation exchange resin resulting from step (c) has levels of incomplete Fc-containing protein that are undetectable by SDS-PAGE under non-reducing conditions and silver staining when loading 1 mcg of Fc-containing protein.
17 . The method according to claim 1 , wherein the incomplete Fc-containing protein fragment comprises free antibody heavy and/or light chains.
18 . The method according to claim 1 , wherein the Fc-containing fluid is clarified harvest.
19 . The method according to claim 1 , wherein the Fc-containing protein has an isoelectric point between about 7.5 and about 9.5.
20 . The method according to claim 1 , further comprising formulating the purified Fc-containing protein into a pharmaceutical composition.Join the waitlist — get patent alerts
Track US2012202974A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.